Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Casulo

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Hematological Oncology|June 9, 2021
Upfront identification of high-risk follicular lymphomaCarla Casulo
Hematology. American Society of Hematology. Education Program|December 10, 2021
Follicular lymphoma: is there an optimal way to define risk?Carla Casulo
Hematology. American Society of Hematology. Education Program|December 4, 2016
Prognostic factors in follicular lymphoma: new tools to personalize riskCarla Casulo
British Journal of Haematology|June 8, 2019
How I manage patients with follicular lymphomaCarla Casulo
Hematology/Oncology Clinics of North America|June 27, 2020
Treatment of Histologic TransformationCarla Casulo
Best Practice & Research. Clinical Haematology|February 18, 2018
Risk stratification in follicular lymphomaCarla Casulo
Hematology. American Society of Hematology. Education Program|December 7, 2024
The POD24 challenge: where do we go from here for early progressors?Patrizia Mondello, Carla Casulo
Current Oncology Reports|November 19, 2021
Early Progressing Follicular LymphomaDanielle Wallace, Carla Casulo
Current Oncology Reports|August 26, 2010
Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Carla Casulo, Steven Horwitz
Hematology/Oncology Clinics of North America|June 24, 2019
Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet NeedsKarim Welaya, Carla Casulo
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Hematological Oncology|June 9, 2021
Upfront identification of high-risk follicular lymphomaCarla Casulo
Hematology. American Society of Hematology. Education Program|December 10, 2021
Follicular lymphoma: is there an optimal way to define risk?Carla Casulo
Hematology. American Society of Hematology. Education Program|December 4, 2016
Prognostic factors in follicular lymphoma: new tools to personalize riskCarla Casulo
British Journal of Haematology|June 8, 2019
How I manage patients with follicular lymphomaCarla Casulo
Hematology/Oncology Clinics of North America|June 27, 2020
Treatment of Histologic TransformationCarla Casulo
Best Practice & Research. Clinical Haematology|February 18, 2018
Risk stratification in follicular lymphomaCarla Casulo
Hematology. American Society of Hematology. Education Program|December 7, 2024
The POD24 challenge: where do we go from here for early progressors?Patrizia Mondello, Carla Casulo
Current Oncology Reports|November 19, 2021
Early Progressing Follicular LymphomaDanielle Wallace, Carla Casulo
Current Oncology Reports|August 26, 2010
Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Carla Casulo, Steven Horwitz
Hematology/Oncology Clinics of North America|June 24, 2019
Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet NeedsKarim Welaya, Carla Casulo
Pageof 9